Abionyx Pharma SA
LSE:0RAG
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Intrinsic Value
The intrinsic value of 
Abionyx Pharma SA (0RAG) under the Base Case is EUR per share.
Compared with the current market price of 1.51 EUR, the stock appears .
The intrinsic value is calculated using valuation multiples.
Do our valuations actually work? See backtest results .
What one share is worth in the bear, base and bull cases.
Create a free account · No card needed
Do our valuations actually work? See backtest results .
Intrinsic value next to the price over the past 5 years, and what happened after valuations like today’s.
Create a free account · No card needed
Fundamental Analysis
What Abionyx Pharma Does
Abionyx Pharma SA is a biotechnology company that develops drug candidates based on a modified form of apolipoprotein A-I, a protein linked to how the body handles inflammation and lipid transport. Its work centers on therapies for serious diseases where the immune system, infection, or organ damage plays a major role, with a lead focus on rare and severe conditions. The company’s value is in turning early-stage scientific research into medicines that can move through clinical development and, if approved, become prescription treatments.
- Headquarters
- France FR
- Employees
- 49
- IPO date
- Mar 30, 2015
Earnings Waterfall
Abionyx Pharma SA
What is the Intrinsic Value of one 0RAG stock?
The intrinsic value for Abionyx Pharma SA (0RAG) under the Base Case is EUR.
Is 0RAG stock undervalued or overvalued?
Compared with the current market price of 1.51 EUR, the stock appears .
